Alginate-Zein Microcarriers with Tunable Stiffness: Fabrication and Application in 3D Osteosarcoma Modeling
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.6c00419 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Yijing Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Multiphase Materials Chemical Engineering, School of Chemical Engineering, School of Mechanical and Power Engineering, Eas…. Hauptthemen laut MEDLINE: Alginates, Zein, Osteosarcoma, Bone Neoplasms. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Engineering of microcarriers with tailored properties is a pivotal challenge in developing physiologically relevant three-dimensional (3D) in vitro tumor models, which are emerging as critical tools in cancer research. This study developed alginate-zein (AZ) composite microcarriers with tuned mechanical properties via a tailored microfluidic device for constructing in vitro 3D osteosarcoma models. A co-axial capillary microfluidic device was prepared to generate AZ microcarriers, and the ratio of calcium alginate to zein was varied. MG-63 were cultured on the microcarriers to obtain proposed osteosarcoma models. Intracellular reactive oxygen species (ROS) levels of these cells were quantified, and qRT-PCR analysis was conducted to examine the expression of genes associated with proliferation, apoptosis, migration, and invasion, along with other promalignancy markers. Doxorubicin was used to validate the utility of this model for drug screening. It was shown that AZ microcarriers were of high uniformity and monodispersity. Cell-microcarrier constructs were formed after MG-63 being cultured on these microcarriers, which further exhibited upregulated intracellular ROS levels and elevated expression of vegf, vim, cdh-2 (n-cadherin), and runx2, alongside downregulated cdh-1 (e-cadherin) expression. The expression of these promalignant markers and observed enhancement in drug resistance by cells within the constructs demonstrated the successful establishment of the expected osteosarcoma model and its application for drug screening. AZ-β microcarriers with a relative zein portion of 9:1 and an elastic modulus of 159.73 kPa were the optimal microcarrier for establishing the osteosarcoma model. This study presented a robust methodology for establishing 3D in vitro tumor models for developing therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Multiphase Materials Chemical Engineering, School of Chemical Engineering, School of Mechanical and Power Engineering, East China University of Science and Technology, No.130 Mei Long Road, Sh…
- Department of Oral and Maxillofacial Implantology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
- College of Stomatology, Shanghai Jiao, Shanghai Jiao Tong University, Shanghai 200011, China.
- National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai 200011, China.
ORCID-Profile: Hongbo Zhang, Xiaomeng Zhang, Lian Cen
Zitieren
APA
Li, Y., Yang, Y., Zhang, H., Zhang, X., & Cen, L. (2026). Alginate-Zein Microcarriers with Tunable Stiffness: Fabrication and Application in 3D Osteosarcoma Modeling. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.6c00419
Vancouver
Li Y, Yang Y, Zhang H, Zhang X, Cen L. Alginate-Zein Microcarriers with Tunable Stiffness: Fabrication and Application in 3D Osteosarcoma Modeling. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.6c00419
BibTeX
@article{Li2026,
author = {Li, Yijing and Yang, Yulin and Zhang, Hongbo and Zhang, Xiaomeng and Cen, Lian},
title = {Alginate-Zein Microcarriers with Tunable Stiffness: Fabrication and Application in 3D Osteosarcoma Modeling},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.6c00419}
}
EUVIMED